4//SEC Filing
Ogren D John 4
Accession 0001140361-12-007012
CIK 0001000229other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:07 PM ET
Size
8.1 KB
Accession
0001140361-12-007012
Insider Transaction Report
Form 4
Ogren D John
Director
Transactions
- Sale
Common Shares
2012-02-10$120.70/sh−5,890$710,944→ 62,100 total - Sale
Common Shares
2012-02-10$121.52/sh−28,082$3,412,398→ 34,018 total - Sale
Common Shares
2012-02-10$122.01/sh−18$2,196→ 34,000 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $120.00 to $120.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $121.00 to $121.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeother
Related Parties
1- filerCIK 0001309016
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 5:07 PM ET
- Size
- 8.1 KB